Ramesh Ramakrishnan - Aug 13, 2021 Form 4 Insider Report for Talis Biomedical Corp (TLIS)

Role
Former Officer
Signature
/s/ J. Roger Moody, Jr., Attorney-in-Fact for Ramesh Ramakrishnan
Stock symbol
TLIS
Transactions as of
Aug 13, 2021
Transactions value $
-$132,133
Form type
4
Date filed
8/17/2021, 05:01 PM

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TLIS Common Stock Options Exercise $65.4K +43.6K +316.82% $1.50 57.4K Aug 13, 2021 Direct
transaction TLIS Common Stock Options Exercise $13.1K +8.74K +15.23% $1.50 66.1K Aug 13, 2021 Direct
transaction TLIS Common Stock Sale -$211K -27.5K -41.59% $7.66 38.6K Aug 13, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock Option (right to buy) Options Exercise $0 -43.6K -100% $0.00* 0 Aug 13, 2021 Common Stock 43.6K $1.50 Direct F2
transaction TLIS Stock Option (right to buy) Options Exercise $0 -8.74K -100% $0.00* 0 Aug 13, 2021 Common Stock 8.47K $1.50 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Ramesh Ramakrishnan is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.38 to $7.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, on request, full information regarding the number of shares sold at each separate price.
F2 1/48th of the shares subject to the option shall vest monthly over the four years from the vesting commencement date.
F3 25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.